Please assess the completion status of the following clinical trial:

Trial Title: Treatment for Alcohol Dependence With Gabapentin

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Age more then 18 years~2. Meet the Diagnostic and Statistical Manual-Fourth Edition (DSM-V) criteria for current alcohol dependence~Exclusion Criteria:~1. Risk for significant withdrawal based on a Clinical Institute Withdrawal Assessment-Alcohol, Revised (CIWA-AR) score \>9~2. More than one month of abstinence~3. Dependence on substances other than alcohol~4. A urine drug screen positive for benzodiazepines or opiates~5. Clinically significant medical or psychiatric disorders treatment with medications that could affect study outcomes~6. Treatment mandated by a legal authority

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: t

Study Arms:
- gabapentin (Type: EXPERIMENTAL): Total subjects 100 (Alcoholic liver disease:Alcoholics with no liver disease= 1:1) each will receive Gabapentin 2g/day divided in two doses for 24 weeks All patient will receive standard of care treatment
- Placebo (Type: PLACEBO_COMPARATOR): Total subjects 100 (Alcoholic liver disease: Alcoholics with no liver disease= 1:1)) each will receive Placebo 2g/day divided in two doses for 24 weeks All patient will receive standard of care treatment

Based on this trial design, predict the completion outcome and termination type (if applicable).